Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer
2020 · Journal of Hematology & Oncology · 142 citations
https://doi.org/10.1186/s13045-020-00852-y
A
Anli Yang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
144
Papers
2.4K
Citations
29
h-index
48
i10-index
Anli Yang is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Cancer-related molecular mechanisms research & MicroRNA in disease regulation. The author has an h-index of 29, co-authored 123 publications.
ORCID: 0000-0003-0966-7285Papers by this author
worksThe Role of Circular RNA CDR1as/ciRS-7 in Regulating Tumor Microenvironment: A Pan-Cancer Analysis
2019 · Biomolecules · 121 citations
https://doi.org/10.3390/biom9090429
circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expression
2019 · Carcinogenesis · 84 citations
https://doi.org/10.1093/carcin/bgz071
crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer
2024 · Drug Resistance Updates · 72 citations
https://doi.org/10.1016/j.drup.2024.101126
CircGFRA1 facilitates the malignant progression of HER‐2‐positive breast cancer via acting as a sponge of miR‐1228 and enhancing AIFM2 expression
2021 · Journal of Cellular and Molecular Medicine · 64 citations
https://doi.org/10.1111/jcmm.16963
Near-Infrared Light-Controlled and Real-Time Detection of Osteogenic Differentiation in Mesenchymal Stem Cells by Upconversion Nanoparticles for Osteoporosis Therapy
2022 · ACS Nano · 64 citations
https://doi.org/10.1021/acsnano.2c02900
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat